SOPHiA GENETICS has partnered with Microsoft and NVIDIA to develop a whole-genome sequencing (WGS) analytical solution to offer streamlined and scalable insights to healthcare providers.
The solution aims to deliver fully analyzed genomic insights within the same day of sequencing. The solution leverages Microsoft Azure and NVIDIA's technology to improve the speed and accuracy of insights, supporting diagnosis and treatment decisions for cancer and rare inherited genetic disorders. The solution, which is slated to be available by the end of the year, aims to enhance clinical research, drug discovery, and care delivery.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.